UTILITY Therapeutics
Dr. Claus Maxel Henriksen is the Acting Head of Project Management at UTILITY therapeutics. Claus has more than 20 years of professional experience working within the international pharmaceutical and food ingredient industries in various line management and project management positions (Chr. Hansen A/S, Novo Nordisk A/S, F. Hoffmann-La Roche). Claus has successfully led and managed numerous cross-disciplinary projects. He brings significant experience within business excellence and process design & optimisation. Academic authorship of numerous journal articles within the fields of microbial physiology and metabolism.
Claus holds a Ph.D in Biotechnology from Technical University of Denmark, and is certified Lean Six-Sigma Black-Belt and Design for Six-Sigma Black-Belt.
This person is not in any teams
This person is not in any offices
UTILITY Therapeutics
UTILITY Therapeutics Ltd., is a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI), to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections.